ISRCTN46576063已完成不适用
Dual steroid and tacrolimus therapy versus steroid withdrawal and tacrolimus therapy in the treatment of posterior segment intraocular inflammation (uveitis)
nited Bristol Healthcare Trust (UK)0 个研究点目标入组 40 人开始时间: 2008年4月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Patients with sight-threatening non-infectious posterior intraocular inflammation (PSII) who:
- •1. Are unable to reduce their prednisone dose to less than 10 mg daily without disease relapse
- •2. Require recurrent high dose steroid rescue for recurrent relapsing disease
- •3. Have severe sight-threatening disease warranting immediate institution of combination immunotherapy (high dose prednisone and a second line agent)
- •4. Are greater than or equal to 18 years old, either sex, and able to give informed consent
排除标准
- •1. Pregnancy or lactation
- •2. Female patients of child bearing age who are unwilling or unable to maintain effective birth control during the study
- •3. Diabetes mellitus (except steroid induced)
- •4. Significant and unstable renal disease (creatinine outside the local laboratories reference range on two consecutive occasions)
- •5. Participating in another clinical trial or has been taking an investigational drug in the past 28 days
- •6. Unlikely to comply with the visits scheduled in the protocol
- •7. Live vaccinations within three months of study entry
- •8. Previous adverse event associated with, or contra-indication to, either prednisolone or tacrolimus
- •9. Concurrent use of other immunosuppressive or cytotoxic agents
- •10. Previous tuberculosis
- •11. Shingles within the past three months
- •12. Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), including current or previous history of opportunistic infections such as cytomegalovirus (CMV), active Pneumocystis carinii, atypical mycobacterium
- •13. Recent history of substance abuse (drug or alcohol)
- •14. Use of cyclosporin A within the last three months
- •15. Serious infections, such as hepatitis, pneumonia, pyelonephritis in the previous three months
研究者
相似试验
已完成
4 期
A comparative study of cyclophosphamide versus tacrolimus based therapy in membranous glomerulonephritis.CTRI/2013/10/004061PGIMER70
已完成
3 期
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.Liver TransplantationNCT00295594Astellas Pharma Inc627
已完成
2 期
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant PatientsLiver TransplantationHepatitis CNCT00295607Astellas Pharma Inc138
招募中
不适用
A Clinical study to compare the effects of two drugs prednisolone and dapsone in patients with oral lichen planusCTRI/2022/06/043594Venkata Ujwala Sahithi
已完成
不适用
Comparison of the effect of steroid therapy in total knee arthroplastyOsteoarthritis kneeJPRN-UMIN000037896Orthopaedic surgery, JCHO gunma central hospital100
